Bartelink H - Search Results

1

The current role of radiotherapy in colorectal cancer.

Aleman BM, Bartelink H, Gunderson LL. Aleman BM, et al. Among authors: bartelink h. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1333-9. doi: 10.1016/0959-8049(95)00280-v. Eur J Cancer. 1995. PMID: 7577046 Review.

2

Radiation therapy, an important mode of treatment for head and neck chemodectomas.

Verniers DA, Keus RB, Schouwenburg PF, Bartelink H. Verniers DA, et al. Among authors: bartelink h. Eur J Cancer. 1992;28A(6-7):1028-33. doi: 10.1016/0959-8049(92)90448-b. Eur J Cancer. 1992. PMID: 1320908 Review.

3

Optimized radiotherapy for head and neck cancer.

Russell NS, Bartelink H. Russell NS, et al. Among authors: bartelink h. Curr Opin Oncol. 1992 Jun;4(3):491-8. doi: 10.1097/00001622-199206000-00011. Curr Opin Oncol. 1992. PMID: 1386755

4

Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy.

Borger JH, van Tienhoven G, Passchier DH, Hart AA, van Dongen JA, Rutgers EJ, Bartelink H. Borger JH, et al. Among authors: bartelink h. Radiother Oncol. 1992 Sep;25(1):1-11. doi: 10.1016/0167-8140(92)90188-z. Radiother Oncol. 1992. PMID: 1410583

5

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.

van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J, et al. van Dongen JA, et al. Among authors: bartelink h. Eur J Cancer. 1992;28A(4-5):801-5. doi: 10.1016/0959-8049(92)90118-l. Eur J Cancer. 1992. PMID: 1524898 Clinical Trial.

6

Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.

van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Winter J, van Zijl K. van Dongen JA, et al. Among authors: bartelink h. J Natl Cancer Inst Monogr. 1992;(11):15-8. J Natl Cancer Inst Monogr. 1992. PMID: 1627421 Clinical Trial.

7

The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials. A quality control study of the EORTC Radiotherapy and Lung Cancer Cooperative Groups.

Schaake-Koning C, Kirkpatrick A, Kröger R, van Zandwijk N, Bartelink H. Schaake-Koning C, et al. Among authors: bartelink h. Eur J Cancer. 1991;27(5):615-9. doi: 10.1016/0277-5379(91)90242-6. Eur J Cancer. 1991. PMID: 1647185 Clinical Trial.

8

Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group.

van Tienhoven G, van Bree NA, Mijnheer BJ, Bartelink H. van Tienhoven G, et al. Among authors: bartelink h. Radiother Oncol. 1991 Dec;22(4):290-8. doi: 10.1016/0167-8140(91)90165-d. Radiother Oncol. 1991. PMID: 1792323 Review.

9

Progress in radiotherapy by treatment tailoring in head and neck cancer.

Bartelink H, Keus RB. Bartelink H, et al. Curr Opin Oncol. 1991 Jun;3(3):523-8. doi: 10.1097/00001622-199106000-00013. Curr Opin Oncol. 1991. PMID: 1892922 Review.

10

Early presentation of results in clinical trials: an ethical dilemma for medicine and science.

Bartelink H, Jassem J. Bartelink H, et al. Eur J Cancer. 1990 Apr;26(4):419-20. doi: 10.1016/0277-5379(90)90006-f. Eur J Cancer. 1990. PMID: 2141504 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters